Topics

UK Court Ruling Ends Novartis/Bayer Crusade Against Avastin In AMD

10:39 EDT 26 Mar 2020 | Elsevier Business Intelligence

AMD patients in the UK can legitimately be given compounded bevacizumab (Roche’s Avastin) after the appeals court said NHS ...

Original Article: UK Court Ruling Ends Novartis/Bayer Crusade Against Avastin In AMD

NEXT ARTICLE

More From BioPortfolio on "UK Court Ruling Ends Novartis/Bayer Crusade Against Avastin In AMD"

Quick Search

Relevant Topics

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...